Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the University of Tsukuba

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 2, 2010, Pages 467-471

  Nakayama, Hidetsugu ^a,c   Sugahara, Shinji ^a   Tokita, Mari ^d   Satoh, Hiroaki ^b   Tsuboi, Koji ^a   Ishikawa, Shigemi ^b   Tokuuye, Koichi ^c,e  

^a UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Tsukuba Medical Center   (Japan)

^d BROWN UNIVERSITY   (United States)

^e TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Lung cancer; Non small cell lung cancer; Proton; Stage I

Indexed keywords

BIOLOGICAL ORGANS; PROTON BEAMS; TUMORS;

CONFIDENCE INTERVAL; LOCAL CONTROL; LUNG CANCER; MEDICALLY INOPERABLE; NON SMALL CELL LUNG CANCER; PROGRESSION FREE SURVIVAL; PROTON BEAM THERAPY; PULMONARY FUNCTION; STATISTICALLY SIGNIFICANT DIFFERENCE; TOTAL DOSE; UNIVERSITY OF TSUKUBA;

PROTONS;

AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; DETERIORATION; DISEASE SEVERITY; FEMALE; HUMAN; JAPAN; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTON RADIATION; PROTON THERAPY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; DISEASE FREE SURVIVAL; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROCEDURES; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY;

PROTON;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77956553924     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.07.1707     Document Type: Article

References (27)

1. D.M. Parkin, F. Bray, and J. Ferlay Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 2001 153 156
2. R.J. Ginsberg, and L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 60 1995 615 622 discussion 622-623
3. S. Tyldesley, C. Boyd, and K. Schulze Estimating the need for radiotherapy for lung cancer: An evidence-based, epidemiologic approach Int J Radiat Oncol Biol Phys 49 2001 973 985
4. X. Qiao, O. Tullgren, and I. Lax The role of radiotherapy in treatment of stage I non-small cell lung cancer Lung Cancer 41 2003 1 11
5. G.S. Sibley Radiotherapy for patients with medically inoperable Stage I nonsmall cell lung carcinoma: Smaller volumes and higher doses - a review Cancer 82 1998 433 438
6. J. Nyman, K.A. Johansson, and U. Hulten Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - mature results for medically inoperable patients Lung Cancer 51 2006 97 103 (Pubitemid 43088629)
7. T. Auberger, K. Seydl, and T. Futschek Photons or protons: Precision radiotherapy of lung cancer Strahlenther Onkol 183 Spec. No. 2 2007 3 6
8. M.F. Moyers, D.W. Miller, and D.A. Bush Methodologies and tools for proton beam design for lung tumors Int J Radiat Oncol Biol Phys 49 2001 1429 1438
9. K. Nihei, T. Ogino, and S. Ishikura High-dose proton beam therapy for Stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 65 2006 107 111
10. D.A. Bush, J.D. Slater, and B.B. Shin Hypofractionated proton beam radiotherapy for stage I lung cancer Chest 126 2004 1198 1203
11. M. Hata, K. Tokuuye, and K. Kagei Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: Preliminary results of a phase I/II clinical study Int J Radiat Oncol Biol Phys 68 2007 786 793
12. M. Urano, L.J. Verhey, and M. Goitein Relative biological effectiveness of modulated proton beams in various murine tissues Int J Radiat Oncol Biol Phys 10 1984 509 514
13. National Cancer Institute CTEP, NCI guidelines: Expedited adverse event reporting requirements for NCI investigational agents 2001 National Cancer Institute Bethesda, MD
14. Y. Tsunashima, T. Sakae, and Y. Shioyama Correlation between the respiratory waveform measured using a respiratory sensor and 3D tumor motion in gated radiotherapy Int J Radiat Oncol Biol Phys 60 2004 951 958
15. H. Shirato, K. Suzuki, and G.C. Sharp Speed and amplitude of lung tumor motion precisely detected in four-dimensional setup and in real-time tumor-tracking radiotherapy Int J Radiat Oncol Biol Phys 64 2006 1229 1236
16. C.M. Fletcher The clinical diagnosis of pulmonary emphysema; An experimental study Proc R Soc Med 45 1952 577 584
17. B.J. Flehinger, M. Kimmel, and M.R. Melamed The effect of surgical treatment on survival from early lung cancer. Implications for screening Chest 101 1992 1013 1018
18. C.F. Mountain Revisions in the International System for Staging Lung Cancer Chest 111 1997 1710 1717
19. R.C. McGarry, L. Papiez, and M. Williams Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study Int J Radiat Oncol Biol Phys 63 2005 1010 1015
20. H. Onishi, T. Araki, and H. Shirato Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study Cancer 101 2004 1623 1631
21. R. Timmerman, R. McGarry, and C. Yiannoutsos Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839
22. M.K. Martel, R.K. Ten Haken, and M.B. Hazuka Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients Lung Cancer 24 1999 31 37
23. H. Asamura, H. Nakayama, and H. Kondo Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: Are these carcinomas candidates for video-assisted lobectomy? J Thorac Cardiovasc Surg 111 1996 1125 1134
24. T. Takizawa, M. Terashima, and T. Koike Lymph node metastasis in small peripheral adenocarcinoma of the lung J Thorac Cardiovasc Surg 116 1998 276 280
25. M. Henderson, R. McGarry, and C. Yiannoutsos Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 72 2008 404 409
26. K. Kadono, T. Homma, and K. Kamahara Effect of heavy-ion radiotherapy on pulmonary function in stage I non-small cell lung cancer patients Chest 122 2002 1925 1932
27. H. Kato, Y. Ichinose, and M. Ohta A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung N Engl J Med 350 2004 1713 1721